Interesting early changes were also observed in the plasma concentrations of plasminogen activator (t-PA) that, surprisingly, was lower in dabigatran-treated mice 24 h after i.v. injection of cancer cells (Figure 4J) what might have facilitated pro-inflammatory activation of macrophages as shown by (Miles and Parmer, 2017). The gene discussed is PLAT; the disease is cancer.